NCT02230826

Brief Summary

This long-term outcomes study is designed to collect safety and efficacy data on designated, commercially available, hip arthroplasty products.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,500

participants targeted

Target at P75+ for all trials

Timeline
226mo left

Started May 2014

Longer than P75 for all trials

Geographic Reach
1 country

13 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
May 2014Dec 2044

Study Start

First participant enrolled

May 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 3, 2014

Completed
20.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2034

Expected
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2044

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

20.6 years

First QC Date

August 29, 2014

Last Update Submit

March 17, 2026

Conditions

Hip ReplacementPrimary, Secondary or Post-traumatic OsteoarthrosisFemur Head NecrosisCongenital DislocationsPrimary and Revision Surgery

Keywords

ArthroplastyHip ReplacementAcetabular cupFemoral stem

Outcome Measures

Primary Outcomes (1)

  • Evaluation of long-term outcome after hip arthroplasty with Corin implants.

    Implants revision rate at 10-year FU hip arthroplasty

    At 10 years

Secondary Outcomes (6)

  • Evaluation of long-term outcome after hip arthroplasty with Corin implants at 15 and 20-year FU.

    at 15- and 20-year

  • Evaluation of clinical performance of Corin hip implants

    starting intraoperatively up to 20-year FU

  • Evaluation of Safety of Corin hip implants

    starting intraoperatively up to 20-year FU

  • Radiological evaluation of positioning and osteointegration of Corin hip implants.

    starting intraoperatively up to 20-year FU

  • Evaluation of patient quality of life

    starting intraoperatively up to 20-year FU

  • +1 more secondary outcomes

Study Arms (1)

Patients with Hip arthroplasty

Patients with Hip implants.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cohort of patients with a partial or total hip replacement (Corin implants)

You may qualify if:

  • Man or woman \>18 years
  • Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study
  • Subjects who agreed for study participation.

You may not qualify if:

  • Subjects with existing tumour and/or particularly high surgical risk-
  • Subjects with anaesthetic risk class IV or higher
  • Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)
  • Contraindications for arthroplasty with a Corin hip devices as per product IFU

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

CHU de Bordeaux - Groupe Hospitalier Pellegrin

Bordeaux, 33000, France

ACTIVE NOT RECRUITING

clinique Oxford Cannes

Cannes, 06400, France

TERMINATED

CH Dunkerque

Dunkirk, 59385, France

TERMINATED

Polyclinique Henin Beaumont

Hénin-Beaumont, 62254, France

RECRUITING

CHU de Nice

Nice, 06000, France

RECRUITING

Centre Hospitalier Régionnal d'Orléans - Site La Source

Orléans, 45000, France

TERMINATED

Clinique Arago

Paris, 75014, France

TERMINATED

Hôpital de la Croix Saint-Simon

Paris, 75020, France

RECRUITING

Hopital privé Saint-Martin

Pessac, 33600, France

ACTIVE NOT RECRUITING

Hôpital Provo

Roubaix, 59100, France

RECRUITING

Polyclinique St Georges de Didonne

Saint-Georges-de-Didonne, 17110, France

RECRUITING

Médipôle Garonne

Toulouse, 31000, France

TERMINATED

Hôpital Jean Bernard

Valenciennes, 59300, France

RECRUITING

MeSH Terms

Conditions

Neoplasm MetastasisFemur Head Necrosis

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and SymptomsOsteonecrosisBone DiseasesMusculoskeletal DiseasesNecrosis

Study Officials

  • Goulven Rochcongar, MD

    University Hospital, Caen

    STUDY CHAIR

Central Study Contacts

Vanessa Grimaud

CONTACT

vanessa.grimaud@coringroup.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2014

First Posted

September 3, 2014

Study Start

May 1, 2014

Primary Completion (Estimated)

December 1, 2034

Study Completion (Estimated)

December 1, 2044

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations

FR(13)